• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Prognostic value of initial serum sodium level in predicting disease severity in patients with COVID-19: A multicenter retrospe

tetano

Editor, Senior Moderator
J Infect Chemother


. 2023 Oct 4:S1341-321X(23)00242-8.
doi: 10.1016/j.jiac.2023.10.002. Online ahead of print. Prognostic value of initial serum sodium level in predicting disease severity in patients with COVID-19: A multicenter retrospective study

Tatsuhiko Hata[SUP] 1 [/SUP], Tadahiro Goto[SUP] 2 [/SUP], Syunsuke Yamanaka[SUP] 3 [/SUP], Tatsuki Matsumoto[SUP] 4 [/SUP], Osamu Yamamura[SUP] 5 [/SUP], Hiroyuki Hayashi[SUP] 6 [/SUP]



Affiliations
Abstract

Introduction: Early prediction of coronavirus disease (COVID-19) severity is crucial. Hyponatremia has been linked to poor outcomes in hospitalized COVID-19 patients, but its association with mild cases is unclear. This study aimed to investigate whether initial serum sodium level is a risk factor for COVID-19 severity in patients with mild-to-moderate disease.
Methods: A multicenter retrospective cohort study was conducted in 10 hospitals in Fukui City, Japan, from July 1, 2020, to October 31, 2021. The study included 1055 adult patients with asymptomatic, mild, or moderate COVID-19 confirmed by a positive RT-PCR test. The primary outcome was the need for oxygen therapy after hospitalization, and the secondary outcome was the composite of in-hospital death and critical care interventions. The association between initial serum sodium level (at the emergency department or on admission) and outcomes was examined, adjusting for age, sex, hypertension, and pneumonia presence.
Results: Of the 1267 patients diagnosed with COVID-19 during the study period, 1055 were eligible (median age: 45 years; 54 % male). Hyponatremia was observed in 5.2 % of patients upon admission. A lower initial serum sodium level was associated with an increased risk of the need for oxygen therapy after hospitalization (adjusted odds ratio [OR] per 1 mmol/L lower, 1.12 [95 % confidence interval {CI}, 1.05-1.19]) and the composite of critical care and in-hospital death (adjusted OR per 1 mmol/L lower, 1.09 [95 % CI, 0.99-1.20]).
Conclusions: Among patients with mild COVID-19, lower initial serum sodium level was a risk factor for COVID-19 progression.

Keywords: COVID-19; Disease progression; Hyponatremia; SARS-CoV-2; Serum sodium.

 
Back
Top Bottom